Multiparametric apparatus for monitoring multiple tissue vitality parameters

• US 20050043606A1
• Filed: 09/25/2001
• Published: 02/24/2005
• Est. Priority Date: 09/25/2001
• Status: Abandoned Application

• Current Assignee: Vital Media
• Original Assignee: Vital Media
• Inventors: Derzy, Igor, Jaronkin, Alexander Vasilievitch, Pewzner, Eliahu, Mayevsky, Avraham
• Application Number:
  US10/490,674
• Publication Number:
  US 20050043606A1
• Time in Patent Office: Days
• US Class Current: 600/407
• CPC Class Codes: A61B 5/0261 using optical means, e.g. infrared light
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

Apparatus for monitoring a plurality of tissue viability parameters of a substantially identical tissue element, in which a single illumination laser source provides illumination radiation at a wavelength such as to enable monitoring of blood flow rate and NADH or flavoprotein concentration, together with blood volume and also blood oxygenation state. In preferred embodiments, an external cavity laser diode system is used to ensure that the laser operates in single mode or at else in two or three non-competing modes, each mode comprising a relatively narrow bandwidth. A laser stabilisation control system is provided to ensure long term operation of the laser source at the desired conditions.

Claims

1. (original) apparatus for selectively monitoring a blood flow rate tissue viability parameter and at least one second tissue viability parameter corresponding to a substantially identical tissue element, the apparatus comprising:

—

illumination means for illuminating at least said tissue element with an illuminating radiation via at least one illumination location with respect to said tissue element;

radiation receiving means for receiving a radiation from said tissue element as a result of an interaction between said illuminating radiation and said tissue element, wherein a part of said received radiation is correlated to said blood flow rate tissue viability parameter, and wherein another part of said received radiation is correlated to said at least one second tissue viability parameter, said radiation receiving means being displaced from said illumination location by a displacement;

characterised in that said illuminating radiation is a laser radiation having a nominal wavelength in the range from about 370 nm to about 470 nm.

2. Apparatus as claimed in claim 1, wherein said laser radiation is generated in stable single longitudinal mode, wherein said nominal wavelength comprises a single waveband element.

3. Apparatus as claimed in claim 1, wherein said laser radiation is generated in two stable longitudinal non-competing modes, wherein said nominal wavelength comprises two discrete waveband elements.

4. Apparatus as claimed in claim 2, wherein said waveband element comprises a bandwidth of about 20 MHz, preferably about 10 MHz, more preferably about 6 MHz, and more preferably about 4 MHz.

5. Apparatus as claimed in claim 3, wherein said waveband elements each comprise a bandwidth of about 20 MHz, preferably about 10 MHz, more preferably about 6 MHz, and more preferably about 4 MHz.

6. Apparatus as claimed in claim 1, wherein said illumination location is provided by at least one excitation optical fiber having a free end capable of being brought into registry with said tissue element.

7. Apparatus as claimed in claim 6, wherein said radiation receiving means comprises at least one suitable receiving optical fiber having a free end capable of being brought into registry with said tissue element.

8. Apparatus as claimed in claim 7, wherein said at least one excitation optical fiber and said at least one receiving optical fiber are housed in a suitable probe head, wherein said free end of said at least one excitation fiber and said free end of said at least one receiving fiber are comprised on a contact face of said probe.

9. Apparatus as claimed in claim 8, wherein said at least one excitation fiber comprises a suitable first connector at an end thereof opposed to said free end thereof, said first connector capable of selectively coupling and decoupling said excitation fiber from the rest of the said apparatus.

10. Apparatus as claimed in claim 9, wherein said at least one collection fiber comprises a suitable second connector at an end thereof opposed to said free end thereof, said second connector capable of selectively coupling and decoupling said collection fiber from the rest of the said apparatus.

11. Apparatus as claimed in claim 8, wherein said probe is disposable.

12. Apparatus as claimed in claim 10, wherein said probe is sterilisable.

13. Apparatus as claimed in claim 1, wherein said illumination means comprises a suitable external cavity laser diode system.

14. Apparatus as claimed in claim 13, wherein said external cavity laser diode system is based on a suitable violet laser diode having an operating wavelength in the range of between about 370 nm and about 470 nm.

15. Apparatus as claimed in claim 14, wherein said external cavity laser diode system is configured according to the Littrow design.

16. Apparatus as claimed in claim 14, wherein said external cavity laser diode system is configured according to the Metcalf-Littman design.

17. Apparatus according to claim 14, wherein said external cavity diode laser system comprises a laser stabilisation control system for substantially preventing operation of the said external cavity diode laser system at mode competition conditions.

18. Apparatus according to claim 17, wherein said laser stabilisation control system is adapted for monitoring the laser intensity of the said external cavity laser diode system at a predetermined input current to said external cavity laser diode system and providing an electrical signal representative of said intensity, for varying the said input current within a predetermined range to provide corresponding electrical signals correlated to the resulting laser intensities generated, for identifying the corresponding electrical signal providing minimum RIN noise levels, and for adjusting the said input current such as to provide and maintain said electrical signal providing minimum RIN noise levels.

19. Apparatus as claimed in claim 1, wherein said blood flow rate tissue viability parameter is provided by applying a laser Doppler flowmetry technique to said radiation received by said radiation receiving means.

20. Apparatus as claimed in claim 19, further comprising first detection means for detecting said received radiation received by said radiation receiving means.

21. Apparatus as claimed in claim 1, wherein said illumination means is adapted to provide said illuminating radiation in pulses of predetermined duration and intensity by correspondingly chopping the illuminating radiation generated by said illuminating means.

22. Apparatus as claimed in claim 21, further comprising suitable control means for controlling the frequency of pulsing of said pulses.

23. Apparatus as claimed in claim 22, wherein said control means is further adapted to provide said pulses in packages of pulses, each package comprising at least one pulse and separated from a preceding or following package by a predetermined time period.

24. Apparatus as claimed in claim 23, wherein said predetermined time period is greater than the time interval between consecutive pulses within a package.

25. Apparatus as claimed in claim 23, wherein said time period is controllably variable.

26. Apparatus as claimed in claim 23, wherein the number of pulses within each package is controllably variable.

27. Apparatus as claimed in claim 1, wherein said nominal wavelength is at wavelength within the NADH excitation spectrum.

28. Apparatus as claimed in claim 27, wherein said nominal wavelength is at a suitable oxy-deoxy isobestic wavelength within the NADH excitation spectrum.

29. Apparatus as claimed in claim 28, wherein said nominal wavelength is about 390 nm±

5 nm.

30. Apparatus as claimed in claim 28, wherein a said at least one second tissue viability parameter is NADH concentration, wherein said radiation received by said radiation receiving means comprises an NADH fluorescence emitted by the tissue in response to illumination thereof by said illuminating radiation, said at least one second tissue viability parameter being provided by the intensity of said NADH fluorescence.

31. Apparatus as claimed in claim 30, further comprising second detection means for detecting said received radiation received by said radiation receiving means.

32. Apparatus as claimed in claim 31, wherein said control means is operatively connected to said second detection means.

33. Apparatus as claimed in claim 32, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said second detection means of a prior monitoring cycle.

34. Apparatus as claimed in claim 28, wherein a said at least one second tissue viability parameter is blood volume within said tissue element, and said corresponding radiation received by said radiation receiving means comprises a reflection from the tissue element in response to illumination thereof by said illuminating radiation, the said at least one second tissue viability parameter being provided by the intensity of said reflection.

35. Apparatus as claimed in claim 34, further comprising third detection means for detecting said received radiation received by said radiation receiving means.

36. Apparatus as claimed in claim 35, wherein said control means is operatively connected to said third detection means.

37. Apparatus as claimed in claim 36, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said third detection means of a prior monitoring cycle.

38. Apparatus as claimed in claim 28, wherein a said at least one second tissue viability parameter is blood oxygenation ratio within said tissue element, and said corresponding radiation received by said radiation receiving means is a fluorescence emitted by the tissue in response to illumination thereof by said illuminating radiation, said at least one second tissue viability parameter being provided by the intensity of said fluorescence at least at two fluorescent emission wavelengths.

39. Apparatus as claimed in claim 38, wherein one of said at least two fluorescent wavelengths is chosen to lie at an oxy-deoxy isosbestic point of the NADH fluorescence emission spectrum.

40. Apparatus as claimed in claim 38, wherein one of said at least two fluorescent wavelengths is higher and another one of said at least two fluorescent wavelengths is smaller than a wavelength corresponding to an oxy-deoxy isosbestic point of the NADH fluorescence emission spectrum.

41. Apparatus as claimed in claim 40, wherein said blood oxygenation ratio parameter is provided by normalising said fluorescent intensities at said two wavelengths with respect to the fluorescent emission intensity at said oxy-deoxy isosbestic point of said NADH fluorescence emission spectrum.

42. Apparatus as claimed in claim 41, wherein said wavelength corresponding to said isosbestic point is about 455 nm±

5 nm.

43. Apparatus as claimed in claim 40, further comprising fourth detection means for detecting said received radiation received by said radiation receiving means.

44. Apparatus as claimed in claim 40, wherein said control means is operatively connected to said fourth detection means.

45. Apparatus as claimed in claim 44, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said fourth detection means of a prior monitoring cycle.

46. Apparatus as claimed in claim 1, wherein said nominal wavelength is at wavelength within the Fp excitation spectrum.

47. Apparatus as claimed in claim 46, wherein said nominal wavelength is at a suitable oxy-deoxy isobestic wavelength within the Fp excitation spectrum.

48. Apparatus as claimed in claim 47, wherein said nominal wavelength is about 455 nm±

5 nm.

49. Apparatus as claimed in claim 47, wherein a said at least one second tissue viability parameter is Fp concentration, wherein said radiation received by said radiation receiving means comprises an Fp fluorescence emitted by the tissue in response to illumination thereof by said illuminating radiation, said at least one second tissue viability parameter being provided by the intensity of said Fp fluorescence.

50. Apparatus as claimed in claim 49, further comprising second detection means for detecting said received radiation received by said radiation receiving means.

51. Apparatus as claimed in claim 50, wherein said control means is operatively connected to said second detection means.

52. Apparatus as claimed in claim 51, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said second detection means of a prior monitoring cycle.

53. Apparatus as claimed in claim 47, wherein a said at least one second tissue viability parameter is blood volume within said tissue element, and said corresponding radiation received by said radiation receiving means comprises a reflection from the tissue element in response to illumination thereof by said illuminating radiation, the said at least one second tissue viability parameter being provided by the intensity of said reflection.

54. Apparatus as claimed in claim 53, further comprising third detection means for detecting said received radiation received by said radiation receiving means.

55. Apparatus as claimed in claim 54, wherein said control means is operatively connected to said third detection means.

56. Apparatus as claimed in claim 55, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said third detection means of a prior monitoring cycle.

57. Apparatus as claimed in claim 47, wherein a said at least one second tissue viability parameter is blood oxygenation ratio within said tissue element, and said corresponding radiation received by said radiation receiving means is a fluorescence emitted by the tissue in response to illumination thereof by said illuminating radiation, said at least one second tissue viability parameter being provided by the intensity of said fluorescence at least at two fluorescent emission wavelengths.

58. Apparatus as claimed in claim 57, wherein one of said at least two fluorescent wavelengths is chosen to lie at an oxy-deoxy isosbestic point of the Fp fluorescence emission spectrum.

59. Apparatus as claimed in claim 57, wherein one of said at least two fluorescent wavelengths is higher and another one of said at least two fluorescent wavelengths is smaller than a wavelength corresponding to an oxy-deoxy isosbestic point of the Fp fluorescence emission spectrum.

60. Apparatus as claimed in claim 59, wherein said blood oxygenation ratio parameter is provided by normalising said fluorescent intensities at said two wavelengths with respect to the fluorescent emission intensity at said oxy-deoxy isosbestic point of said Fp fluorescence emission spectrum.

61. Apparatus as claimed in claim 60, wherein said wavelength corresponding to said isosbestic point is about 530 nm±

5 nm.

62. Apparatus as claimed in claim 59, further comprising fourth detection means for detecting said received radiation received by said radiation receiving means.

63. Apparatus as claimed in claim 59, wherein said control means is operatively connected to said fourth detection means.

64. Apparatus as claimed in claim 63, wherein said control means is selectively responsive to previously detected signals corresponding to the detection of said received radiation detected by means of said fourth detection means of a prior monitoring cycle.

65. Apparatus as claimed in claim 46, wherein said nominal wavelength is about 440 mm±

5 nm.

66. Apparatus as claimed in claim 22, wherein said control means is operatively connected to said first detection means.

67. A system for selectively monitoring at least two tissue viability parameter at a plurality of tissue elements;

said system comprising a plurality of monitoring probes, each said probe comprising an apparatus as claimed in claim 1.

68. A system as claimed in claim 67, wherein at least two said probes are adapted for monitoring said tissue viability parameters of tissue elements within the same organ.

69. A system as claimed in claim 67, wherein at least two said probes are adapted for monitoring said tissue viability parameters of tissue elements within different organs.

70. A system as claimed in claim 69, wherein different organs are different organs within the same organism.

71. A system as claimed in claim 69, wherein different organs are different organs within different organisms.

72. A system as claimed in claim 69, wherein different organs are different organs include donor organs.

73. A system as claimed in claim 67, wherein said illuminating radiation for each said probe is provided by a common suitable light source.

74. A system as claimed in claim 73, wherein said first light source is a laser light source.

75. A system as claimed in claim 74, wherein said laser light source is adapted to provide said first illuminating radiation of said first wavelength in second pulses of predetermined duration and intensity.

76. A system as claimed in claim 75, further comprising suitable control means for controlling the frequency of pulsing of said second pulses.

77. A system as claimed in claim 76, wherein said control means is further adapted to provide said second pulses in packages of pulses, each package comprising at least one second pulse and separated from a preceding or following package by a predetermined time period.

78. A system as claimed in claim 77, wherein said predetermined time period is greater than the time interval between consecutive pulses within a package.

79. A system as claimed in claim 78, wherein said time period is controllably variable.

80. A system as claimed in claim 77, wherein the number of second pulses within each package is controllably variable.

81. A system as claimed in claim 77, wherein said control means is adapted for selectively directing discrete said second pulses to any one of said probes.